Search Results Search Sort by RelevanceMost Recent State of the Art and Science Aug 2020 American College of Preventive Medicine Statement on Prioritizing Prevention in Opioid Research Hunter Jackson Smith, MD, MPH, MBE, Elizabeth Salisbury-Afshar, MD, MPH, Bob Carr, MD, MPH, and Stephanie Zaza, MD, MPH Opioid use research has focused mainly on treatment and overdose responses. Clinically and ethically, these priorities should change. AMA J Ethics. 2020;22(8):E687-694. doi: 10.1001/amajethics.2020.687. State of the Art and Science Sep 2017 Swift and Certain, Proportionate and Consistent: Key Values of Urine Drug Test Consequences for Probationers Amy B. Cadwallader, PhD Probation programs that use a frequent, random urine drug testing (UDT) coupled with swift consequences for violations reduce drug use and recidivism. AMA J Ethics. 2017;19(9):931-938. doi: 10.1001/journalofethics.2017.19.9.stas2-1709. State of the Art and Science Dec 2016 Locating Risk in the Adolescent Brain: Ethical Challenges in the Use of Biomarkers for Adolescent Health and Social Policy Suparna Choudhury, PhD and Sheehan Moore Neurobiological markers raise complex questions about what it means to be “at risk.” AMA J Ethics. 2016;18(12):1199-1206. doi: 10.1001/journalofethics.2016.18.12.stas1-1612. State of the Art and Science Sep 2005 Approach to the Patient with Alcoholic Liver Disease Howard J. Worman, MD Virtual Mentor. 2005;7(9):600-603. doi: 10.1001/virtualmentor.2005.7.9.cprl1-0509. State of the Art and Science Sep 2017 Why It’s Inappropriate Not to Treat Incarcerated Patients with Opioid Agonist Therapy Sarah E. Wakeman, MD Although effective, opioid agonist therapy is associated with stigma and thus underutilized for treatment of opioid use disorder in incarcerated settings. AMA J Ethics. 2017;19(9):922-930. doi: 10.1001/journalofethics.2017.19.9.stas1-1709. State of the Art and Science Jul 2004 Diagnosing Anabolic Steroid Use Audiey C. Kao, MD, PhD Virtual Mentor. 2004;6(7):316-317. doi: 10.1001/virtualmentor.2004.6.7.cprl1-0407 State of the Art and Science Jan 2004 Treatment of Dependence on Opiate Medications Norman S. Miller, MD Virtual Mentor. 2004;6(1):33-37. doi: 10.1001/virtualmentor.2004.6.1.cprl1-0401. State of the Art and Science Mar 2003 Diagnosing Alcohol Abuse and Treating Withdrawal Syndrome Audiey Kao, MD, PhD Virtual Mentor. 2003;5(3):91-93. doi: 10.1001/virtualmentor.2003.5.3.cprl1-0303. State of the Art and Science Feb 2001 Gene Therapy or Genetic Enhancement: Does It Make a Difference? Faith Lagay, PhD Virtual Mentor. 2001;3(2):37-39. doi: 10.1001/virtualmentor.2001.3.2.gnth1-0102. State of the Art and Science Dec 2000 Is Genetic Enhancement a Gift to Future Generations? Faith Lagay, PhD Virtual Mentor. 2000;2(12):136-138. doi: 10.1001/virtualmentor.2000.2.12.gnth1-0012. Pagination Current page 1 Page 2 Next page Next › Last page Last »
State of the Art and Science Aug 2020 American College of Preventive Medicine Statement on Prioritizing Prevention in Opioid Research Hunter Jackson Smith, MD, MPH, MBE, Elizabeth Salisbury-Afshar, MD, MPH, Bob Carr, MD, MPH, and Stephanie Zaza, MD, MPH Opioid use research has focused mainly on treatment and overdose responses. Clinically and ethically, these priorities should change. AMA J Ethics. 2020;22(8):E687-694. doi: 10.1001/amajethics.2020.687.
State of the Art and Science Sep 2017 Swift and Certain, Proportionate and Consistent: Key Values of Urine Drug Test Consequences for Probationers Amy B. Cadwallader, PhD Probation programs that use a frequent, random urine drug testing (UDT) coupled with swift consequences for violations reduce drug use and recidivism. AMA J Ethics. 2017;19(9):931-938. doi: 10.1001/journalofethics.2017.19.9.stas2-1709.
State of the Art and Science Dec 2016 Locating Risk in the Adolescent Brain: Ethical Challenges in the Use of Biomarkers for Adolescent Health and Social Policy Suparna Choudhury, PhD and Sheehan Moore Neurobiological markers raise complex questions about what it means to be “at risk.” AMA J Ethics. 2016;18(12):1199-1206. doi: 10.1001/journalofethics.2016.18.12.stas1-1612.
State of the Art and Science Sep 2005 Approach to the Patient with Alcoholic Liver Disease Howard J. Worman, MD Virtual Mentor. 2005;7(9):600-603. doi: 10.1001/virtualmentor.2005.7.9.cprl1-0509.
State of the Art and Science Sep 2017 Why It’s Inappropriate Not to Treat Incarcerated Patients with Opioid Agonist Therapy Sarah E. Wakeman, MD Although effective, opioid agonist therapy is associated with stigma and thus underutilized for treatment of opioid use disorder in incarcerated settings. AMA J Ethics. 2017;19(9):922-930. doi: 10.1001/journalofethics.2017.19.9.stas1-1709.
State of the Art and Science Jul 2004 Diagnosing Anabolic Steroid Use Audiey C. Kao, MD, PhD Virtual Mentor. 2004;6(7):316-317. doi: 10.1001/virtualmentor.2004.6.7.cprl1-0407
State of the Art and Science Jan 2004 Treatment of Dependence on Opiate Medications Norman S. Miller, MD Virtual Mentor. 2004;6(1):33-37. doi: 10.1001/virtualmentor.2004.6.1.cprl1-0401.
State of the Art and Science Mar 2003 Diagnosing Alcohol Abuse and Treating Withdrawal Syndrome Audiey Kao, MD, PhD Virtual Mentor. 2003;5(3):91-93. doi: 10.1001/virtualmentor.2003.5.3.cprl1-0303.
State of the Art and Science Feb 2001 Gene Therapy or Genetic Enhancement: Does It Make a Difference? Faith Lagay, PhD Virtual Mentor. 2001;3(2):37-39. doi: 10.1001/virtualmentor.2001.3.2.gnth1-0102.
State of the Art and Science Dec 2000 Is Genetic Enhancement a Gift to Future Generations? Faith Lagay, PhD Virtual Mentor. 2000;2(12):136-138. doi: 10.1001/virtualmentor.2000.2.12.gnth1-0012.